Loading…

Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas

Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples fro...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 1998-01, Vol.77 (2), p.297-304
Main Authors: Protiva, P, Sordat, I, Chaubert, P, Saraga, E, Trén-Thang, C, Sordat, B, Blum, AL, Dorta, G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163
cites
container_end_page 304
container_issue 2
container_start_page 297
container_title British journal of cancer
container_volume 77
creator Protiva, P
Sordat, I
Chaubert, P
Saraga, E
Trén-Thang, C
Sordat, B
Blum, AL
Dorta, G
description Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P < 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P < 0.001 and P < 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P < 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.
doi_str_mv 10.1038/bjc.1998.46
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2151227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79682513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163</originalsourceid><addsrcrecordid>eNp1kUtv1DAUhS0EKkNhxRqRBWIDGfxIJvamUlXxkiqxgbV149ykHjn2YDtF_fc4zGgECza2rPP53GMfQl4yumVUyA_93myZUnLb7B6RDWsFr5nk3WOyoZR2NVWcPiXPUtqXo6KyuyAXqtkxStmGzNcuY4Rsg0-V9dXBQZqtDxP6Cky293-kyoQY0UHG6pfNdxUeyorOgqsMOlcND2m9aKGaIgzWT6uVCS5ENLlAMKAPM6Tn5MkILuGL035Jfnz6-P3mS3377fPXm-vb2jSK5no0gis54thgPzTc9HwHHR1aoaQaJW97iULgODAjpcS2xVFB31FALiQTbCcuydXR97D0Mw4GfY7g9CHaGeKDDmD1v4q3d3oK95qzlnHeFYO3J4MYfi6Ysp5tWp8KHsOSdKd2JQcTBXx3BE0MKUUcz0MY1Ws7urSj13Z0s-Z69XeuM3uqo-hvTjokA26M4I1NZ4yXbLRtCvb-iKWi-Amj3ocl-vKj_5n6-oh7yEvEs11hVqQQvwF3nrUh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79682513</pqid></control><display><type>article</type><title>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</title><source>PMC (PubMed Central)</source><creator>Protiva, P ; Sordat, I ; Chaubert, P ; Saraga, E ; Trén-Thang, C ; Sordat, B ; Blum, AL ; Dorta, G</creator><creatorcontrib>Protiva, P ; Sordat, I ; Chaubert, P ; Saraga, E ; Trén-Thang, C ; Sordat, B ; Blum, AL ; Dorta, G</creatorcontrib><description>Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P &lt; 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P &lt; 0.001 and P &lt; 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P &lt; 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1998.46</identifier><identifier>PMID: 9461001</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adenoma - enzymology ; Adenoma - pathology ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Colorectal Neoplasms - enzymology ; Colorectal Neoplasms - pathology ; Drug Resistance ; Enzyme Activation ; Epidemiology ; Epithelial Cells - enzymology ; experimental-oncology ; Female ; Fibrinolysin - metabolism ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Medical sciences ; Middle Aged ; Molecular Medicine ; Oncology ; Plasminogen - metabolism ; Plasminogen Activator Inhibitor 1 - metabolism ; Plasminogen Activators - metabolism ; Prospective Studies ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tissue Plasminogen Activator - metabolism ; Tumors ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>British journal of cancer, 1998-01, Vol.77 (2), p.297-304</ispartof><rights>Cancer Research Campaign 1998</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151227/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151227/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4022,27922,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2122054$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9461001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Protiva, P</creatorcontrib><creatorcontrib>Sordat, I</creatorcontrib><creatorcontrib>Chaubert, P</creatorcontrib><creatorcontrib>Saraga, E</creatorcontrib><creatorcontrib>Trén-Thang, C</creatorcontrib><creatorcontrib>Sordat, B</creatorcontrib><creatorcontrib>Blum, AL</creatorcontrib><creatorcontrib>Dorta, G</creatorcontrib><title>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P &lt; 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P &lt; 0.001 and P &lt; 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P &lt; 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.</description><subject>Adenoma - enzymology</subject><subject>Adenoma - pathology</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Colorectal Neoplasms - enzymology</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Drug Resistance</subject><subject>Enzyme Activation</subject><subject>Epidemiology</subject><subject>Epithelial Cells - enzymology</subject><subject>experimental-oncology</subject><subject>Female</subject><subject>Fibrinolysin - metabolism</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Plasminogen - metabolism</subject><subject>Plasminogen Activator Inhibitor 1 - metabolism</subject><subject>Plasminogen Activators - metabolism</subject><subject>Prospective Studies</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tissue Plasminogen Activator - metabolism</subject><subject>Tumors</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp1kUtv1DAUhS0EKkNhxRqRBWIDGfxIJvamUlXxkiqxgbV149ykHjn2YDtF_fc4zGgECza2rPP53GMfQl4yumVUyA_93myZUnLb7B6RDWsFr5nk3WOyoZR2NVWcPiXPUtqXo6KyuyAXqtkxStmGzNcuY4Rsg0-V9dXBQZqtDxP6Cky293-kyoQY0UHG6pfNdxUeyorOgqsMOlcND2m9aKGaIgzWT6uVCS5ENLlAMKAPM6Tn5MkILuGL035Jfnz6-P3mS3377fPXm-vb2jSK5no0gis54thgPzTc9HwHHR1aoaQaJW97iULgODAjpcS2xVFB31FALiQTbCcuydXR97D0Mw4GfY7g9CHaGeKDDmD1v4q3d3oK95qzlnHeFYO3J4MYfi6Ysp5tWp8KHsOSdKd2JQcTBXx3BE0MKUUcz0MY1Ws7urSj13Z0s-Z69XeuM3uqo-hvTjokA26M4I1NZ4yXbLRtCvb-iKWi-Amj3ocl-vKj_5n6-oh7yEvEs11hVqQQvwF3nrUh</recordid><startdate>199801</startdate><enddate>199801</enddate><creator>Protiva, P</creator><creator>Sordat, I</creator><creator>Chaubert, P</creator><creator>Saraga, E</creator><creator>Trén-Thang, C</creator><creator>Sordat, B</creator><creator>Blum, AL</creator><creator>Dorta, G</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199801</creationdate><title>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</title><author>Protiva, P ; Sordat, I ; Chaubert, P ; Saraga, E ; Trén-Thang, C ; Sordat, B ; Blum, AL ; Dorta, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adenoma - enzymology</topic><topic>Adenoma - pathology</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Colorectal Neoplasms - enzymology</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Drug Resistance</topic><topic>Enzyme Activation</topic><topic>Epidemiology</topic><topic>Epithelial Cells - enzymology</topic><topic>experimental-oncology</topic><topic>Female</topic><topic>Fibrinolysin - metabolism</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Plasminogen - metabolism</topic><topic>Plasminogen Activator Inhibitor 1 - metabolism</topic><topic>Plasminogen Activators - metabolism</topic><topic>Prospective Studies</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tissue Plasminogen Activator - metabolism</topic><topic>Tumors</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Protiva, P</creatorcontrib><creatorcontrib>Sordat, I</creatorcontrib><creatorcontrib>Chaubert, P</creatorcontrib><creatorcontrib>Saraga, E</creatorcontrib><creatorcontrib>Trén-Thang, C</creatorcontrib><creatorcontrib>Sordat, B</creatorcontrib><creatorcontrib>Blum, AL</creatorcontrib><creatorcontrib>Dorta, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Protiva, P</au><au>Sordat, I</au><au>Chaubert, P</au><au>Saraga, E</au><au>Trén-Thang, C</au><au>Sordat, B</au><au>Blum, AL</au><au>Dorta, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1998-01</date><risdate>1998</risdate><volume>77</volume><issue>2</issue><spage>297</spage><epage>304</epage><pages>297-304</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P &lt; 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P &lt; 0.001 and P &lt; 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P &lt; 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>9461001</pmid><doi>10.1038/bjc.1998.46</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 1998-01, Vol.77 (2), p.297-304
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2151227
source PMC (PubMed Central)
subjects Adenoma - enzymology
Adenoma - pathology
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Colorectal Neoplasms - enzymology
Colorectal Neoplasms - pathology
Drug Resistance
Enzyme Activation
Epidemiology
Epithelial Cells - enzymology
experimental-oncology
Female
Fibrinolysin - metabolism
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Male
Medical sciences
Middle Aged
Molecular Medicine
Oncology
Plasminogen - metabolism
Plasminogen Activator Inhibitor 1 - metabolism
Plasminogen Activators - metabolism
Prospective Studies
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tissue Plasminogen Activator - metabolism
Tumors
Urokinase-Type Plasminogen Activator - metabolism
title Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T01%3A07%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20in%20plasminogen%20activation%20correlate%20with%20epithelial%20cell%20dysplasia%20grading%20in%20colorectal%20adenomas&rft.jtitle=British%20journal%20of%20cancer&rft.au=Protiva,%20P&rft.date=1998-01&rft.volume=77&rft.issue=2&rft.spage=297&rft.epage=304&rft.pages=297-304&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1998.46&rft_dat=%3Cproquest_pubme%3E79682513%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79682513&rft_id=info:pmid/9461001&rfr_iscdi=true